MC1R-selective small melanocortin analogs for mela...
Melanoma is the deadliest form of skin cancer, and despite the exciting advancements in treatment, there is still no cure for late stage disease. The incidence of...
March 31, 2026
Melanoma is the deadliest form of skin cancer, and despite the exciting advancements in treatment, there is still no cure for late stage disease. The incidence of...
Melanoma immunotherapy works by stimulating immune cells to kill tumor. In many cases, immune cells are drawn to tumor by immunogenic proteins on the surface...
Melanoma, one of the most aggressive and fatal neoplasms, is responsible for over 80% of skin cancer-related deaths. As melanoma mostly expresses tumor-specific neo-antigen...
Study Goals: Reveal how a molecule called neuritin supports a population of immune cells that actively interferes with the killing of melanomas; determine if ther...
Description: Melanoma of the uveal tract (a region of the eye) is the most common ocular malignancy in adults and accounts for 5% of all melanomas. According to N...
Description: Mutations in a small number of genes are found in a large fraction of human melanomas. For instance, so-called “driver” mutations in the “famous” melan...
Description: Treatment of advanced melanoma with immunotherapy agents shows striking responses in some patients, however overall responses are low. In addition, a significa...
Established Investigator Award – Ashani Weeraratna, PhD
CURE OM funded award Established Investigator — CURE OM – John Sondek
Established Investigator Award – Rutao Cui
Established Investigator Award – Linda Bradley
Established Investigator Award – Dr. Ze’ev Ronai
Apr 06, 2026 ET
Apr 17, 2026 ET - Apr 19, 2026
Apr 19, 2026 PT
May 02, 2026 PT